{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:50:29Z","timestamp":1790722229350,"version":"4.1.0"},"reference-count":78,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.celrep.2025.116063","type":"journal-article","created":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T15:32:29Z","timestamp":1753543949000},"page":"116063","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Identification and engineering of potent bispecific antibodies that protect against herpes simplex virus recurrent disease"],"prefix":"10.1016","volume":"44","author":[{"given":"Chingwei V.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector","family":"Viadiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apurva","family":"Kalamkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David I.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Pae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinchao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando J.","family":"Bravo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elbert","family":"Seto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdeleine","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimei","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe A.","family":"Papalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majlinda","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Jarrousse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Mercier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan M.","family":"Holdorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon P.","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Abernathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2025.116063_bib1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2471\/BLT.19.237149","article-title":"Herpes simplex virus: global infection prevalence and incidence estimates, 2016","volume":"98","author":"James","year":"2020","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.celrep.2025.116063_bib2","first-page":"1","article-title":"Prevalence of Herpes Simplex Virus Type 1 and Type 2 in Persons Aged 14-49: United States, 2015-2016","author":"McQuillan","year":"2018","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.celrep.2025.116063_bib3","doi-asserted-by":"crossref","DOI":"10.1186\/s44263-024-00053-6","article-title":"Estimated global and regional economic burden of genital herpes simplex virus infection among 15\u201349 year-olds in 2016","volume":"2","author":"Chaiyakunapruk","year":"2024","journal-title":"BMC Glob. Public Health"},{"key":"10.1016\/j.celrep.2025.116063_bib4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11908-017-0568-7","article-title":"Herpes Simplex Encephalitis: an Update","volume":"19","author":"Gnann","year":"2017","journal-title":"Curr. Infect. Dis. Rep."},{"key":"10.1016\/j.celrep.2025.116063_bib5","series-title":"Hot Topics in Infection and Immunity in Children VII","first-page":"221","author":"Thompson","year":"2011"},{"key":"10.1016\/j.celrep.2025.116063_bib6","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S1473-3099(19)30470-0","article-title":"Global and regional estimates of the contribution of herpes simplex virus type 2 infection to HIV incidence: a population attributable fraction analysis using published epidemiological data","volume":"20","author":"Looker","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.celrep.2025.116063_bib7","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.3233\/JAD-230718","article-title":"Herpes Simplex Viral Infection Doubles the Risk of Dementia in a Contemporary Cohort of Older Adults: A Prospective Study","volume":"97","author":"Vestin","year":"2024","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.celrep.2025.116063_bib8","first-page":"170A","article-title":"Prevention of herpes simplex virus type 2 transmission with antiviral therapy","volume":"11","author":"Corey","year":"2004","journal-title":"Herpes"},{"key":"10.1016\/j.celrep.2025.116063_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","article-title":"Sexually Transmitted Infections Treatment Guidelines, 2021","volume":"70","author":"Workowski","year":"2021","journal-title":"MMWR Recomm. Rep. (Morb. Mortal. Wkly. Rep.)"},{"key":"10.1016\/j.celrep.2025.116063_bib10","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/s41579-020-00448-w","article-title":"The structural basis of herpesvirus entry","volume":"19","author":"Connolly","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.celrep.2025.116063_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JVI.76.1.1-8.2002","article-title":"Directed egress of animal viruses promotes cell-to-cell spread","volume":"76","author":"Johnson","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.celrep.2025.116063_bib12","doi-asserted-by":"crossref","first-page":"8933","DOI":"10.1128\/JVI.72.11.8933-8942.1998","article-title":"The herpes simplex virus gE-gI complex facilitates cell-to-cell spread and binds to components of cell junctions","volume":"72","author":"Dingwell","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.celrep.2025.116063_bib13","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1056\/NEJM198603203141205","article-title":"Infections with herpes simplex viruses (2)","volume":"314","author":"Corey","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.celrep.2025.116063_bib14","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1128\/JVI.74.8.3909-3917.2000","article-title":"Cell-to-cell spread of wild-type herpes simplex virus type 1, but not of syncytial strains, is mediated by the immunoglobulin-like receptors that mediate virion entry, nectin1 (PRR1\/HveC\/HIgR) and nectin2 (PRR2\/HveB)","volume":"74","author":"Cocchi","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.celrep.2025.116063_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007095","article-title":"Vaccine-induced antibodies to herpes simplex virus glycoprotein D epitopes involved in virus entry and cell-to-cell spread correlate with protection against genital disease in guinea pigs","volume":"14","author":"Hook","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2025.116063_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1143870","article-title":"Cell-to-cell spread inhibiting antibodies constitute a correlate of protection against herpes simplex virus type 1 reactivations: A retrospective study","volume":"14","author":"Alt","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2025.116063_bib17","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00070-19","article-title":"Cell-to-Cell Spread Blocking Activity Is Extremely Limited in the Sera of Herpes Simplex Virus 1 (HSV-1)- and HSV-2-Infected Subjects","volume":"93","author":"Criscuolo","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.celrep.2025.116063_bib18","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.1128\/jvi.63.11.4479-4488.1989","article-title":"A novel function of the herpes simplex virus type 1 Fc receptor: participation in bipolar bridging of antiviral immunoglobulin G","volume":"63","author":"Frank","year":"1989","journal-title":"J. Virol."},{"key":"10.1016\/j.celrep.2025.116063_bib19","doi-asserted-by":"crossref","first-page":"7046","DOI":"10.1128\/jvi.65.12.7046-7050.1991","article-title":"Herpes simplex virus type 1 Fc receptor protects infected cells from antibody-dependent cellular cytotoxicity","volume":"65","author":"Dubin","year":"1991","journal-title":"J. Virol."},{"key":"10.1016\/j.celrep.2025.116063_bib20","first-page":"109","article-title":"Direct evidence for antibody bipolar bridging on herpes simplex virus-infected cells","volume":"77","author":"Van Vliet","year":"1992","journal-title":"Immunology"},{"key":"10.1016\/j.celrep.2025.116063_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003961","article-title":"The herpes virus Fc receptor gE-gI mediates antibody bipolar bridging to clear viral antigens from the cell surface","volume":"10","author":"Ndjamen","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2025.116063_bib22","doi-asserted-by":"crossref","first-page":"8421","DOI":"10.1128\/JVI.01130-14","article-title":"Blocking herpes simplex virus 2 glycoprotein E immune evasion as an approach to enhance efficacy of a trivalent subunit antigen vaccine for genital herpes","volume":"88","author":"Awasthi","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.celrep.2025.116063_bib23","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1080\/21645515.2017.1323604","article-title":"A trivalent subunit antigen glycoprotein vaccine as immunotherapy for genital herpes in the guinea pig genital infection model","volume":"13","author":"Awasthi","year":"2017","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.celrep.2025.116063_bib24","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1111\/cts.13365","article-title":"First-in-human, randomized, double-blind, placebo-controlled, dose escalation trial of the anti-herpes simplex virus monoclonal antibody HDIT101 in healthy volunteers","volume":"15","author":"Blank","year":"2022","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.celrep.2025.116063_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.959603","article-title":"Monoclonal antibody therapy of herpes simplex virus: An opportunity to decrease congenital and perinatal infections","volume":"13","author":"Backes","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2025.116063_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003495","article-title":"Safety, acceptability, and pharmacokinetics of a monoclonal antibody-based vaginal multipurpose prevention film (MB66): A Phase I randomized trial","volume":"18","author":"Politch","year":"2021","journal-title":"PLoS Med."},{"key":"10.1016\/j.celrep.2025.116063_bib27","doi-asserted-by":"crossref","first-page":"6760","DOI":"10.1073\/pnas.1220019110","article-title":"Overcoming drug-resistant herpes simplex virus (HSV) infection by a humanized antibody","volume":"110","author":"Krawczyk","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2025.116063_bib28","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1128\/JVI.01924-10","article-title":"Impact of valency of a glycoprotein B-specific monoclonal antibody on neutralization of herpes simplex virus","volume":"85","author":"Krawczyk","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.celrep.2025.116063_bib29","unstructured":"Lai, J.-S., Y.-S. Lin, and W.-E. Chan. Development Center for Biotechnology, LLC, assignee. 2010. Anti-herpes simplex virus antibodies. World Intellectual Property Organization patent WO\/2010\/087813A1, filed January 5, 2009, and issued August 5, 2010."},{"key":"10.1016\/j.celrep.2025.116063_bib30","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1006\/viro.1996.0011","article-title":"Protection of nude mice by passive immunization with a type-common human recombinant monoclonal antibody against HSV","volume":"215","author":"Sanna","year":"1996","journal-title":"Virology"},{"key":"10.1016\/j.celrep.2025.116063_bib31","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12929-024-01045-2","article-title":"Development of a highly effective combination monoclonal antibody therapy against Herpes simplex virus","volume":"31","author":"Seyfizadeh","year":"2024","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.celrep.2025.116063_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23095009","article-title":"Camelid Single-Domain Antibodies: Promises and Challenges as Lifesaving Treatments","volume":"23","author":"Arbabi-Ghahroudi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.celrep.2025.116063_bib33","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1146\/annurev-biochem-063011-092449","article-title":"Nanobodies: natural single-domain antibodies","volume":"82","author":"Muyldermans","year":"2013","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.celrep.2025.116063_bib34","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1093\/emboj\/19.5.921","article-title":"Camel heavy-chain antibodies: diverse germline V(H)H and specific mechanisms enlarge the antigen-binding repertoire","volume":"19","author":"Nguyen","year":"2000","journal-title":"EMBO J."},{"key":"10.1016\/j.celrep.2025.116063_bib35","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nsb0996-803","article-title":"Crystal structure of a camel single-domain VH antibody fragment in complex with lysozyme","volume":"3","author":"Desmyter","year":"1996","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.celrep.2025.116063_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004966","article-title":"Capacity of Broadly Neutralizing Antibodies to Inhibit HIV-1 Cell-Cell Transmission Is Strain- and Epitope-Dependent","volume":"11","author":"Reh","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2025.116063_bib37","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1107\/S0907444913016776","article-title":"Structural basis for the antibody neutralization of herpes simplex virus","volume":"69","author":"Lee","year":"2013","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.celrep.2025.116063_bib38","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/protein\/9.7.617","article-title":"Knobs-into-holes' engineering of antibody CH3 domains for heavy chain heterodimerization","volume":"9","author":"Ridgway","year":"1996","journal-title":"Protein Eng."},{"key":"10.1016\/j.celrep.2025.116063_bib39","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1080\/19420862.2016.1197457","article-title":"The use of CrossMAb technology for the generation of bi- and multispecific antibodies","volume":"8","author":"Klein","year":"2016","journal-title":"mAbs"},{"key":"10.1016\/j.celrep.2025.116063_bib40","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2023.2236265","article-title":"Generation and engineering of potent single domain antibody-based bispecific IL-18 mimetics resistant to IL-18BP decoy receptor inhibition","volume":"15","author":"Lipinski","year":"2023","journal-title":"mAbs"},{"key":"10.1016\/j.celrep.2025.116063_bib41","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abc1726","article-title":"The prefusion structure of herpes simplex virus glycoprotein B","volume":"6","author":"Vollmer","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.celrep.2025.116063_bib42","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2115435118","article-title":"Development of a universal nanobody-binding Fab module for fiducial-assisted cryo-EM studies of membrane proteins","volume":"118","author":"Bloch","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2025.116063_bib43","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1097-2765(01)00298-2","article-title":"Herpes simplex virus glycoprotein D bound to the human receptor HveA","volume":"8","author":"Carf\u00ed","year":"2001","journal-title":"Mol. Cell"},{"key":"10.1016\/j.celrep.2025.116063_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002277","article-title":"Structure of herpes simplex virus glycoprotein D bound to the human receptor nectin-1","volume":"7","author":"Di Giovine","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2025.116063_bib45","article-title":"Evaluation of HSV-2 gE Binding to IgG-Fc and Application for Vaccine Development","volume":"10","author":"Galli","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.celrep.2025.116063_bib46","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1097\/INF.0000000000001916","article-title":"Safety, Tolerability and Pharmacokinetics of MEDI8897, an Extended Half-life Single-dose Respiratory Syncytial Virus Prefusion F-targeting Monoclonal Antibody Administered as a Single Dose to Healthy Preterm Infants","volume":"37","author":"Domachowske","year":"2018","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.celrep.2025.116063_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0040148","article-title":"Crystal structure of the HSV-1 Fc receptor bound to Fc reveals a mechanism for antibody bipolar bridging","volume":"4","author":"Sprague","year":"2006","journal-title":"PLoS Biol."},{"key":"10.1016\/j.celrep.2025.116063_bib48","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1128\/jvi.56.2.489-494.1985","article-title":"Specificity of Fc receptors induced by herpes simplex virus type 1: comparison of immunoglobulin G from different animal species","volume":"56","author":"Johansson","year":"1985","journal-title":"J. Virol."},{"key":"10.1016\/j.celrep.2025.116063_bib49","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jim.2008.11.019","article-title":"A novel method to determine the engulfment of apoptotic cells by macrophages using pHrodo succinimidyl ester","volume":"342","author":"Miksa","year":"2009","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.celrep.2025.116063_bib50","doi-asserted-by":"crossref","first-page":"23514","DOI":"10.1074\/jbc.M604292200","article-title":"Properties of human IgG1s engineered for enhanced binding to the neonatal Fc receptor (FcRn)","volume":"281","author":"Dall'Acqua","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.celrep.2025.116063_bib51","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1038\/s12276-022-00870-5","article-title":"An Fc variant with two mutations confers prolonged serum half-life and enhanced effector functions on IgG antibodies","volume":"54","author":"Ko","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.celrep.2025.116063_bib52","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.06054","article-title":"Herpes simplex type 2 virus deleted in glycoprotein D protects against vaginal, skin and neural disease","volume":"4","author":"Petro","year":"2015","journal-title":"eLife"},{"key":"10.1016\/j.celrep.2025.116063_bib53","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41541-020-0184-7","article-title":"Model of vaccine efficacy against HSV-2 superinfection of HSV-1 seropositive mice demonstrates protection by antibodies mediating cellular cytotoxicity","volume":"5","author":"Burn Aschner","year":"2020","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.celrep.2025.116063_bib54","article-title":"Greater Durability and Protection against Herpes Simplex Viral Disease following Immunization of Mice with Single-Cycle DeltagD-2 Compared to an Adjuvanted Glycoprotein D Protein Vaccine","volume":"11","author":"Mahant","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.celrep.2025.116063_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0260954","article-title":"Fc-engineered antibodies with immune effector functions completely abolished","volume":"16","author":"Wilkinson","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2025.116063_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/v16071037","article-title":"Small Animal Models to Study Herpes Simplex Virus Infections","volume":"16","author":"Hussain","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.celrep.2025.116063_bib57","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/095632020701800104","article-title":"Superior efficacy of helicase-primase inhibitor BAY 57-1293 for herpes infection and latency in the guinea pig model of human genital herpes disease","volume":"18","author":"Baumeister","year":"2007","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.celrep.2025.116063_bib58","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1743-422X-1-11","article-title":"Prevention of genital herpes in a guinea pig model using a glycoprotein D-specific single chain antibody as a microbicide","volume":"1","author":"Chen","year":"2004","journal-title":"Virol. J."},{"key":"10.1016\/j.celrep.2025.116063_bib59","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/intimm\/13.12.1551","article-title":"Differences in promiscuity for antibody-FcRn interactions across species: implications for therapeutic antibodies","volume":"13","author":"Ober","year":"2001","journal-title":"Int. Immunol."},{"key":"10.1016\/j.celrep.2025.116063_bib60","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1093\/intimm\/dxl110","article-title":"Enhanced half-life of genetically engineered human IgG1 antibodies in a humanized FcRn mouse model: potential application in humorally mediated autoimmune disease","volume":"18","author":"Petkova","year":"2006","journal-title":"Int. Immunol."},{"key":"10.1016\/j.celrep.2025.116063_bib61","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s11274-024-03990-4","article-title":"Nanobodies in the fight against infectious diseases: repurposing nature's tiny weapons","volume":"40","author":"Rizk","year":"2024","journal-title":"World J. Microbiol. Biotechnol."},{"key":"10.1016\/j.celrep.2025.116063_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006777","article-title":"Two classes of protective antibodies against Pseudorabies virus variant glycoprotein B: Implications for vaccine design","volume":"13","author":"Li","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2025.116063_bib63","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1128\/JVI.02710-06","article-title":"Antigenic and mutational analyses of herpes simplex virus glycoprotein B reveal four functional regions","volume":"81","author":"Bender","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.celrep.2025.116063_bib64","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1038\/s41467-020-17911-0","article-title":"A glycoprotein B-neutralizing antibody structure at 2.8 A uncovers a critical domain for herpesvirus fusion initiation","volume":"11","author":"Oliver","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2025.116063_bib65","doi-asserted-by":"crossref","first-page":"10309","DOI":"10.1128\/JVI.75.21.10309-10318.2001","article-title":"Herpes simplex virus with highly reduced gD levels can efficiently enter and spread between human keratinocytes","volume":"75","author":"Huber","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.celrep.2025.116063_bib66","doi-asserted-by":"crossref","first-page":"12501","DOI":"10.1128\/JVI.02097-15","article-title":"Bispecific Antibodies Targeting Different Epitopes on the HIV-1 Envelope Exhibit Broad and Potent Neutralization","volume":"89","author":"Asokan","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.celrep.2025.116063_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2024.109902","article-title":"A tetravalent bispecific antibody outperforms the combination of its parental antibodies and neutralizes diverse SARS-CoV-2 variants","volume":"260","author":"Chiyyeadu","year":"2024","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.celrep.2025.116063_bib68","article-title":"Ultrapotent Broadly Neutralizing Human-llama Bispecific Antibodies against HIV-1","volume":"11","author":"Xu","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.celrep.2025.116063_bib69","doi-asserted-by":"crossref","DOI":"10.3390\/v16091476","article-title":"Toward the Eradication of Herpes Simplex Virus: Vaccination and Beyond","volume":"16","author":"Chang","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.celrep.2025.116063_bib70","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1186\/s12967-023-04553-1","article-title":"Mechanisms and research advances in mRNA antibody drug-mediated passive immunotherapy","volume":"21","author":"Zhao","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.celrep.2025.116063_bib71","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1001\/jama.2016.18189","article-title":"Effect of Pritelivir Compared With Valacyclovir on Genital HSV-2 Shedding in Patients With Frequent Recurrences","volume":"316","author":"Wald","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.celrep.2025.116063_bib72","article-title":"Herpes Simplex Virus Type 1 Propagation, Titration and Single-step Growth Curves","volume":"9","author":"Grosche","year":"2019","journal-title":"Bio. Protoc."},{"key":"10.1016\/j.celrep.2025.116063_bib73","series-title":"Phage Display Methods and Protocols","author":"Hust","year":"2018"},{"key":"10.1016\/j.celrep.2025.116063_bib74","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ab.2005.09.034","article-title":"Analyzing a kinetic titration series using affinity biosensors","volume":"349","author":"Karlsson","year":"2006","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.celrep.2025.116063_bib75","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2021.2020203","article-title":"BioPhi: A platform for antibody design, humanization, and humanness evaluation based on natural antibody repertoires and deep learning","volume":"14","author":"Prihoda","year":"2022","journal-title":"mAbs"},{"key":"10.1016\/j.celrep.2025.116063_bib76","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s42003-023-04927-7","article-title":"ImmuneBuilder: Deep-Learning models for predicting the structures of immune proteins","volume":"6","author":"Abanades","year":"2023","journal-title":"Commun. Biol."},{"key":"10.1016\/j.celrep.2025.116063_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2023.105733","article-title":"Intermittent therapy with helicase-primase inhibitor IM-250 efficiently controls recurrent herpes disease and reduces reactivation of latent HSV","volume":"219","author":"Bernstein","year":"2023","journal-title":"Antivir. Res."},{"key":"10.1016\/j.celrep.2025.116063_bib78","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/infdis\/146.3.397","article-title":"Genital herpes in guinea pigs: pathogenesis of the primary infection and description of recurrent disease","volume":"146","author":"Stanberry","year":"1982","journal-title":"J. Infect. Dis."}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124725008344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124725008344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T13:24:01Z","timestamp":1783171441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124725008344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":78,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S2211124725008344"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2025.116063","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification and engineering of potent bispecific antibodies that protect against herpes simplex virus recurrent disease","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2025.116063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116063"}}